13F

Stock

Neurocrine Biosciences Inc

NBIX · held by 7 managers

Reported value

$48M

Holders

7

+1 new · −0 exited

Holders’ est. mark

$16M

Price effect on 5 books still in the name

Largest holder

$22.4M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC162.4K$22.4M$16MCut−$14.3M
DANSKE BANK A/S138.4K$19.1M−$33.6KAdded$528.9K
ONTARIO TEACHERS PENSION PLAN BOARD31.4K$4.33M−$7.2KAdded$354.5K
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main12.1K$1.67M−$3.03KCut−$2.26M
Swiss Life Asset Management Ltd3.96K$545.3KNew
Leonteq Securities AG224$30.8K−$49Added$3.53K
Prestige Wealth Management Group LLC23$3.17KHeld

Who left

Positions as of Q2 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.